BioNTech gibt Update zu Entwicklungsplänen für nachhaltige Lösungen gegen Infektionskrankheiten auf dem afrikanischen Kontinent
26 juil. 2021 10h00 HE
|
BioNTech SE
BioNTech will den ersten mRNA-basierten Impfstoff zur Malaria-Prävention entwickeln und plant den Start einer klinischen Studie bis Ende 2022 BioNTech prüft nachhaltige Lösungen für...
BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent
26 juil. 2021 10h00 HE
|
BioNTech SE
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022BioNTech is evaluating sustainable mRNA vaccine production capacities...
Der Kampf gegen Infektionskrankheiten auf dem afrikanischen Kontinent
23 juil. 2021 09h50 HE
|
BioNTech SE
Der afrikanische Kontinent kämpft gegen einen überproportional hohen Anteil der globalen Infektionskrankheiten. Die außerordentlichen wissenschaftlichen Fortschritte, die während der COVID-19-Pandemie...
Fighting Infectious Diseases on the African Continent
23 juil. 2021 09h50 HE
|
BioNTech SE
The African continent carries a disproportionately high share of the global infectious disease burden. The extraordinary scientific progress made during the COVID-19 pandemic gives hope in addressing...
Canadian business and philanthropic leaders call on their peers to #ShareTheHealth and donate to UNICEF’s COVID-19 Global Vaccination Efforts
27 mai 2021 08h30 HE
|
UNICEF Canada
Toronto, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- Today, 16 senior leaders from top Canadian companies and foundations, including Teck Resources Limited and Fairmount Foundation, released an Open...
Global Smart Commodity Group Partners with Advanced Hemp Processing
28 avr. 2021 14h00 HE
|
Global Smart Commodity Group
CHICAGO, April 28, 2021 (GLOBE NEWSWIRE) -- Global Smart Commodity Group (GSCG) is thrilled to be working with Advanced Hemp Processing (AHP) who is now GMP certified to Annex 2 WHO. With this...
Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
23 avr. 2021 09h00 HE
|
Meningitis Foundation
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- This World Meningitis Day (April 24th), Meningitis Foundation Canada (MFC) is raising awareness of this ‘indiscriminate killer disease’ and...
BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator
15 nov. 2020 19h35 HE
|
BioAegis Therapeutics
No drug-related safety signals identified by the independent Data and Safety Monitoring Board.MORRISTOWN, N.J., Nov. 15, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage,...
WHO Leader to Address CONV2X 2020
05 nov. 2020 16h10 HE
|
Partners in Digital Health
STAMFORD, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- World Health Organization (WHO) Director - General Dr. Tedros Adhanom Ghebreyesus will address the 4th Annual ConVerge2Xcelerate (#CONV2X) 2020...
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
26 oct. 2020 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...